Introduction: Idiopathic pulmonary arterial hypertension (iPAH) is a rare, life-shortening disease. Symptoms are non-specific with diagnosis usually made at a late stage. Aims and objectives: The study aim was to… Click to show full abstract
Introduction: Idiopathic pulmonary arterial hypertension (iPAH) is a rare, life-shortening disease. Symptoms are non-specific with diagnosis usually made at a late stage. Aims and objectives: The study aim was to develop a predictive algorithm (Sheffield Pulmonary Hypertension IndeX, SPHInX) to identify iPAH, with a diagnostic performance that would allow large population screening. Methods: Data collected at Sheffield for iPAH patients (n=852) were linked with pre-diagnosis National Health Service (HES) records capturing in-, outpatient, accident and emergency attendances. Non-iPAH patients (n=11,209,000) were selected from the HES population, enriched by excluding those without selected ICD-10 codes felt to make a diagnosis of iPAH unlikely. Patient history was limited to ≤5 yrs pre-diagnosis. Demographics, timing/frequency of diagnoses, medical specialities visits and procedures undertaken were captured. For predictive modelling a gradient boosting tree with bootstrap aggregation was used to discriminate between iPAH and non-iPAH. Results: To identify 100 iPAH patients, 969 patients would need to be screened: specificity 99.99%, sensitivity 14.1%, positive, negative predictive values 10.3%; 99.99%, respectively. The timing/frequency of hospital visits, the speciality seen, age were key drivers of model performance. Conclusion: Predictive algorithms using existing and accessible real-world data have the potential to determine patients at high risk of having iPAH. Studies to validate this approach to screen for iPAH in the general population are now warranted.
               
Click one of the above tabs to view related content.